Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas

被引:24
|
作者
Yamanaka, Takashi [1 ]
Yamakado, Koichiro [1 ]
Takaki, Haruyuki [1 ]
Nakatsuka, Atsuhiro [1 ]
Shiraki, Katsuya [2 ]
Hasegawa, Hiroshi [3 ]
Takei, Yoshiyuki [2 ]
Takeda, Kan [1 ]
机构
[1] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 5148507, Japan
[2] Mie Univ, Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie 5148507, Japan
[3] Mie Chuo Med Ctr, Dept Internal Med, Tsu, Mie 5141101, Japan
关键词
Abdomen; Ablation procedure; Chemoembolization; Liver cirrhosis; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; TREATMENT RESPONSE; THERMAL ABLATION; SINGLE-SESSION; TUMOR ABLATION; GELATIN SPONGE; RISK-FACTORS; CM; EMBOLIZATION; THERAPY;
D O I
10.1007/s11604-012-0087-2
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
We retrospectively evaluated whether combined use of chemoembolization expands ablative zone sizes created by radiofrequency (RF) ablation in patients with small hepatocellular carcinomas (HCCs). Fifty-seven patients treated with single RF ablation for solitary HCC measuring a parts per thousand currency sign2 cm were assessed. RF ablation alone was done in nine patients and in 48 patients following chemoembolization, with an interval of 0 days in 6, 1-14 days in 27, 15-28 days in 6, and a parts per thousand yen4 weeks in 9. Ablative zone sizes, disappearance of tumor enhancement, and creation of sufficient ablative margins (> 5 mm) were evaluated on contrast-enhanced computed tomography (CT) images. Both mean long-axis (4.2-4.7 vs. 3.6 +/- A 0.4 cm, p < 0.04) and short-axis (3.3-3.8 vs. 2.3 +/- A 0.5 cm, p < 0.03) diameters were expanded significantly when RF ablation was done until 4 weeks after chemoembolization than with RF ablation alone. Tumor enhancement disappeared in all patients. Frequency of achieving sufficient ablative margins was significantly higher when RF ablation was done until 4 weeks after chemoembolization than with RF ablation alone (74.0-83.3 vs. 22.2 %, p < 0.05). Ablative zones created by RF ablation with chemoembolization become larger than RF ablation alone, leading to secure ablative margins.
引用
收藏
页码:553 / 559
页数:7
相关论文
共 50 条
  • [1] Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas
    Takashi Yamanaka
    Koichiro Yamakado
    Haruyuki Takaki
    Atsuhiro Nakatsuka
    Katsuya Shiraki
    Hiroshi Hasegawa
    Yoshiyuki Takei
    Kan Takeda
    Japanese Journal of Radiology, 2012, 30 : 553 - 559
  • [2] Radiofrequency ablation in the treatment of small hepatocellular carcinomas: Comparison of the radiofrequency effect with and without chemoembolization
    Kitamoto, M
    Imagawa, M
    Yamada, H
    Watanabe, C
    Sumioka, M
    Satoh, O
    Shimamoto, M
    Kodama, M
    Kimura, S
    Kishimoto, K
    Okamoto, Y
    Fukuda, Y
    Dohi, K
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 181 (04) : 997 - 1003
  • [3] Radiofrequency ablation combined with transcatheter arterial chemoembolization for small hepatocellular carcinomas
    Aikata, Hiroshi
    Shirakawa, Hiroo
    Takaki, Shintaro
    Uka, Kiminori
    Miki, Daiki
    Yamashina, Keitaro
    Hiramatsu, Akira
    Takahashi, Shoichi
    Chayama, Kazuaki
    HEPATOLOGY, 2006, 44 (04) : 494A - 494A
  • [4] Radiofrequency ablation combined with transcatheter arterial chemoembolization for small hepatocellular carcinomas
    Aikata, H
    Takaki, S
    Tei, S
    Ishihara, H
    Takahashi, S
    Chayama, K
    GASTROENTEROLOGY, 2004, 126 (04) : A737 - A737
  • [5] Radiofrequency ablation with or without transcatheter arterial chemoembolization for small hepatocellular carcinoma; a propensity analysis
    Kim, Hee Yeon
    Kim, Chang Wook
    Kim, Yu Seung
    Yoon, Seung Kew
    Choi, Jong Young
    Bae, Si Hyun
    Lee, Chang Don
    HEPATOLOGY, 2014, 60 : 885A - 885A
  • [6] Radiofrequency Ablation Combined With Chemoembolization: Treatment of Recurrent Hepatocellular Carcinomas After Hepatectomy
    Takaki, Haruyuki
    Yamakado, Koichiro
    Sakurai, Hiroshi
    Nakatsuka, Atsuhiro
    Shiraki, Katsuya
    Isaji, Syuji
    Takeda, Kan
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2011, 197 (02) : 488 - 494
  • [7] Effects of sorafenib combined with chemoembolization and radiofrequency ablation for large, unresectable hepatocellular carcinomas
    Liang Heng-yi
    Lu Li-gong
    Hu Bao-shan
    Li Yong
    Shao Pei-jian
    CHINESE MEDICAL JOURNAL, 2013, 126 (22) : 4270 - 4276
  • [8] Treatment Strategy for Early Hepatocellular Carcinomas: Comparison of Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization and Surgical Resection
    Tashiro, Hirotaka
    Aikata, Hiroshi
    Waki, Koji
    Amano, Hironobu
    Oshita, Akihiko
    Kobayashi, Tsuyoshi
    Tanimoto, Yoshisato
    Kuroda, Shintaro
    Tazawa, Hirofumi
    Chayama, Kazuaki
    Asahara, Toshimasa
    Ohdan, Hideki
    JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (01) : 3 - 9
  • [9] Radiofrequency ablation and chemoembolization for hepatocellular carcinoma
    Georgiades, Christos S.
    Hong, Kelvin
    Geschwind, Jean-Francois
    CANCER JOURNAL, 2008, 14 (02): : 117 - 122
  • [10] Comparative effectiveness of radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma
    Kong, Qing-Feng
    Jiao, Jun-Bo
    Chen, Qian-Qian
    Li, Long
    Wang, Dong-Guang
    Lv, Bin
    TUMOR BIOLOGY, 2014, 35 (03) : 2655 - 2659